ChemoCentryx Announces Abstract on Avacopan in ANCA-Associated Vasculitis Selected as One of the Ten Best Abstracts at the ERA-EDTA CongressGlobeNewsWire • 06/08/21
Kessler Topaz Meltzer & Check, LLP - Important Deadline Reminder for ChemoCentryx, Inc. InvestorsNewsfile Corp • 06/07/21
SHAREHOLDER ALERT: Kessler Topaz Meltzer & Check, LLP Announces Securities Fraud Class Action Lawsuit Filed Against ChemoCentryx, Inc.PRNewsWire • 06/05/21
ROSEN, RESPECTED INVESTOR COUNSEL, Encourages ChemoCentryx, Inc. Investors to Secure Counsel Before Important July 6 Deadline in Securities Class Action - CCXIPRNewsWire • 06/05/21
HAGENS BERMAN Encourages ChemoCentryx (CCXI) Investors with Losses to Contact its Attorneys, Securities Class Action PendingNewsfile Corp • 06/04/21
LAWSUIT FILED: Block & Leviton LLP Has Filed a Lawsuit Against ChemoCentryx, Inc. for Securities Fraud; Investors Who Lost Money Should Contact the FirmNewsfile Corp • 06/03/21
CCXI Breaking Notice: Rosen, A Leading Investor Rights Law Firm, Encourages ChemoCentryx, Inc. Investors with Losses to Secure Counsel Before Important Deadline - CCXINewsfile Corp • 06/02/21
Important Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds ChemoCentryx, Inc. Investors of Securities Fraud Class Action LawsuitNewsfile Corp • 06/02/21
HAGENS BERMAN Encourages ChemoCentryx (CCXI) Investors with Losses to Contact the Firm Now, Securities Fraud Lawsuit PendingNewsfile Corp • 06/01/21
ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages ChemoCentryx, Inc. Investors with Losses to Secure Counsel Before Important Deadline – CCXIBusiness Wire • 05/30/21
Kessler Topaz Meltzer & Check, LLP: Securities Fraud Class Action Filed Against ChemoCentryx, Inc.PRNewsWire • 05/30/21
CCXI Alert: Did You Buy ChemoCentryx Public Offering Shares in June 2020? Contact Johnson Fistel Regarding InvestigationPRNewsWire • 05/28/21
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages ChemoCentryx (CCXI) Investors with Losses to Contact the Firm to Recover Losses Due to Alleged Securities FraudNewsfile Corp • 05/27/21
Important Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds ChemoCentryx, Inc. Investors of Deadline in Securities Fraud Class Action LawsuitNewsfile Corp • 05/26/21
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of ChemoCentryx, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 6, 2021 - CCXINewsfile Corp • 05/26/21
HAGENS BERMAN Alerts ChemoCentryx (CCXI) Investors to Securities Fraud Lawsuit, Encourages Investors with Losses to Contact the Firm Before Application DeadlineNewsfile Corp • 05/24/21
CCXI ALERT: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against ChemoCentryx, Inc.PRNewsWire • 05/24/21
CCXI Breaking Notice: Rosen, Top Ranked Investor Counsel, Encourages ChemoCentryx, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline - CCXINewsfile Corp • 05/23/21
ChemoCentryx News: Berger Montague Investigates Securities Fraud Allegations Against ChemoCentryx, Inc. (CCXI); Lead Plaintiff Deadline is July 6, 2021Newsfile Corp • 05/22/21
ChemoCentryx Stock: Berger Montague Investigates Securities Fraud Allegations Against ChemoCentryx, Inc. (CCXI); Lead Plaintiff Deadline is July 6, 2021Newsfile Corp • 05/21/21
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts ChemoCentryx (CCXI) Investors to Securities Fraud Class Action, Encourages Investors with Losses to Contact the FirmNewsfile Corp • 05/21/21
Shareholder Alert: Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of Securities Fraud Class Action Lawsuit Filed Against ChemoCentryx, Inc.Newsfile Corp • 05/21/21
CCXI Stock: Berger Montague Investigates Securities Fraud Allegations Against ChemoCentryx, Inc. (CCXI); Lead Plaintiff Deadline is July 6, 2021Newsfile Corp • 05/20/21
ROSEN, NATIONAL TRIAL LAWYERS, Encourages ChemoCentryx, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline - CCXIPRNewsWire • 05/20/21
